A hope.
While the pandemic continues to wreak havoc around the world, and particularly in Europe, the vaccine against Covid-19 developed by Pfizer and Biontech is "90% effective", say the two laboratories on Monday.
They are based on the first interim analysis of their phase 3 trial, the last before an application for registration.
This “vaccine efficacy” was measured by comparing the number of participants infected with the new coronavirus in the group that received the vaccine and in that on placebo, “seven days after the second dose” and 28 days after the first, have- they explained in a joint statement.
> More information to follow.